Atlas Trials

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure

Clinical trial NCT03030222 · COMPLETED

Trial details

NCT number
NCT03030222
Sponsor
Saint Luke's Health System
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2017-07-05
Primary completion
2020-03-10
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.